Filtros de búsqueda

Lista de obras de Christian Marth

2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference ⬇️

artículo científico publicado el 1 de mayo de 2011

A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer

artículo científico publicado en 2004

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

scientific article published on 01 February 2019

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

artículo científico publicado en 2006

A pooled analysis of bone marrow micrometastasis in breast cancer

artículo científico publicado en 2005

AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).

artículo científico publicado en 2017

AGO Austria recommendations for genetic testing of patients with ovarian cancer

artículo científico publicado en 2015

Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancer.

artículo científico publicado en 2008

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.

artículo científico publicado en 2012

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 19 February 2019

Adjuvant endocrine therapy of premenopausal women with early breast cancer: an overview

artículo científico publicado en 2010

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

artículo científico publicado en 2008

Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

artículo científico publicado en 2010

Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors

artículo científico publicado en 2004

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool

scientific article published on 01 November 2004

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer

artículo científico publicado en 2002

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

artículo científico publicado en 2016

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer ⬇️

artículo científico publicado el 23 de noviembre de 2012

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

artículo científico publicado en 2004

Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

artículo científico publicado en 2013

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

artículo científico publicado en 2018

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer

artículo científico publicado en 2018

Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases

artículo científico publicado en 2003

Blood dissemination of mammaglobin-specific RNA during core needle biopsy in patients with invasive breast carcinoma

artículo científico publicado en 2004

Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.

artículo científico publicado en 2006

Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening

artículo científico publicado en 2010

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients

scientific article published on 01 March 2004

Calgranulins in cystic fluid and serum from patients with ovarian carcinomas ⬇️

artículo científico publicado el 1 de noviembre de 2003

Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria

artículo científico publicado en 2015

Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma

artículo científico publicado en 2007

Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer

artículo científico publicado en 1996

Circulating tumor cells in metastatic breast cancer--toward individualized treatment?

artículo científico publicado en 2004

Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis

artículo científico publicado en 2002

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

artículo científico publicado en 2005

Clinical Impact of RANK Signalling in Ovarian Cancer

artículo científico publicado en 2019

Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting ⬇️

artículo científico publicado el 15 de noviembre de 2010

Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort

artículo científico publicado en 2020

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer

artículo científico publicado en 2020

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.

artículo científico publicado en 2016

Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGO-a focus on surgical aspects

scientific article published on 01 January 2019

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients

artículo científico publicado en 2007

Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature

artículo científico publicado en 2011

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo

artículo científico publicado en 2005

Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions

artículo científico publicado en 2004

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

artículo científico publicado en 2020

Congenital fibrosarcoma as cause for fetal anemia: prenatal diagnosis and in utero treatment

scientific article published on 19 November 2008

Conservative management of abnormally invasive placenta: four case reports ⬇️

artículo científico publicado el 14 de febrero de 2013

Contralateral prophylactic mastectomy in women with breast cancer without a family history or genetic predisposition : Consensus statement from the Austrian Gynecologic Oncology Working Group of the Austrian Society of Obstetrics and Gynecology

artículo científico publicado en 2019

Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009

artículo científico publicado en 2010

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

artículo científico publicado en 2016

Cyclin E dysregulation and chromosomal instability in endometrial cancer

artículo científico publicado en 2004

DNA hypomethylation and ovarian cancer biology.

artículo científico publicado en 2004

DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients

scientific article published on 01 June 2004

DNA methylation in serum and tumors of cervical cancer patients

artículo científico publicado en 2004

DNA methylation in serum of breast cancer patients: an independent prognostic marker

scientific article published on 01 November 2003

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer ⬇️

artículo científico publicado el 20 de enero de 2011

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

artículo científico publicado en 2020

Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history

artículo científico publicado en 2004

Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.

artículo científico publicado en 2006

Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1.

artículo científico publicado en 2017

Disseminated tumor cells: are they ready for clinical use?

artículo científico publicado en 2007

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

artículo científico publicado en 2016

Dual-energy contrast-enhanced spectral mammography (CESM).

artículo científico publicado en 2015

Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease

artículo científico publicado en 2006

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

artículo científico publicado en 2010

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

artículo científico publicado en 2016

ESGO Statement on the Role of CA‐125 Measurement in Follow-Up of Epithelial Ovarian Cancer

artículo científico publicado en 2012

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

artículo científico publicado en 2016

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

artículo científico publicado en 2015

Effect of tension-free vaginal tape operation on urethral closure function

artículo científico publicado en 2006

Effects of adjustable dynamic bedroom lighting in a maternity ward

artículo científico publicado en 2019

Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation: Primary analysis of the EPIK-O trial

artículo científico publicado en 2024

Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT

artículo científico publicado en 2020

Endocrine Therapy - What Else?

artículo científico publicado en 2008

Endometroid carcinoma developing in endometriosis over the symphysis pubis

artículo científico publicado el 10 de septiembre de 2013

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer

scientific article published on 29 February 2020

Erythropoetin beta twice weekly versus standard therapy in patients with gynaecological malignancies--a randomised Austrian AGO trial

artículo científico publicado en 2008

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

artículo científico publicado en 2010

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

artículo científico publicado en 2015

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

artículo científico publicado en 2016

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

scientific article published on 01 September 2017

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.

scientific article published on 24 May 2016

Evaluation of Vav3.1 as prognostic marker in endometrial cancer

artículo científico publicado en 2018

Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy

artículo científico publicado en 2003

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.

artículo científico publicado en 2016

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

artículo científico publicado en 2020

Evaluation of three mRNA markers for the detection of lymph node metastases

artículo científico publicado en 2006

Evidence for Cosmetics as a Source of Mineral Oil Contamination in Women

artículo científico publicado en 2011

Experience with trabectedin + pegylated liposomal doxorubicin for recurrent platinum-sensitive ovarian cancer unsuited to platinum rechallenge

artículo científico publicado en 2016

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.

artículo científico publicado en 2016

Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer

artículo científico publicado en 2008

Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer

artículo científico publicado en 2006

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2017

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

artículo científico publicado en 2007

Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report ⬇️

artículo científico publicado el 18 de julio de 2011

Favorable prognostic value of SOCS2 and IGF-I in breast cancer

artículo científico publicado en 2007

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

artículo científico publicado en 2016

Genetic analyses in a variant of Mayer-Rokitansky-Kuster-Hauser syndrome (MURCS association).

artículo científico publicado en 2008

Genome-scale screen for DNA methylation-based detection markers for ovarian cancer

artículo científico publicado en 2011

Genomic index of sensitivity to endocrine therapy for breast cancer.

artículo científico publicado en 2010

Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients

artículo científico publicado en 2014

HE4 is an independent prognostic marker in endometrial cancer patients ⬇️

artículo científico publicado el 21 de abril de 2012

Hair Safe Study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer therapy—A prospective interventional study.

scientific article published on 06 June 2022

Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study

artículo científico publicado en 2022

Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF.

artículo científico publicado en 2006

High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer

artículo científico publicado en 2010

High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome

scientific article published on 19 December 2019

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

artículo científico publicado en 2015

Hopes and failures in front-line ovarian cancer therapy

artículo científico publicado en 2019

Human papillomavirus DNA in sera of cervical cancer patients as tumor marker

artículo científico publicado en 2003

Immune cells in colorectal cancer

artículo científico publicado en 2006

Immunotherapy in ovarian cancer: fake news or the real deal?

scientific article published on 01 January 2019

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

artículo científico publicado en 2011

Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer

artículo científico publicado el 1 de septiembre de 2010

Incorporation of pazopanib in maintenance therapy of ovarian cancer

artículo científico publicado en 2014

Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology

artículo científico publicado en 2009

Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium

artículo científico publicado en 2014

Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

artículo científico publicado en 2004

International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)

artículo científico publicado en 2010

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.

artículo científico publicado en 2009

Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase

artículo científico publicado en 2011

Is neoadjuvant chemotherapy in ovarian cancer an excuse for insufficient surgery?

artículo científico publicado en 2011

Joint ENGOT and GOG Foundation requirements for trials with industry partners

scientific article published on 18 July 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners

artículo científico publicado en 2019

Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are Unsatisfactory

scholarly article by Olaf Reich et al published December 2018 in Geburtshilfe und Frauenheilkunde: Ergebnisse der Forschung für die Praxis

L1CAM and HER2 Expression in Early Endometrioid Uterine Cancer

artículo científico publicado en 2017

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

artículo científico publicado en 2013

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

artículo científico publicado en 2020

Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

artículo científico publicado en 2009

Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer

artículo científico publicado en 2004

Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction.

artículo científico publicado en 2002

Managing relapsed ovarian cancer in a rapidly evolving landscape

artículo científico publicado en 2017

Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions

artículo científico publicado en 2007

Methylated DNA collected by tampons--a new tool to detect endometrial cancer.

artículo científico publicado en 2004

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

artículo científico publicado en 2004

Migrants and obstetrics in Austria—applying a new questionnaire shows differences in obstetric care and outcome ⬇️

artículo científico publicado el 5 de enero de 2013

Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab

artículo científico publicado en 2007

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

artículo científico publicado en 2023

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer

scientific article published on 01 February 2019

Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer ⬇️

artículo científico publicado el 1 de febrero de 2012

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

artículo científico publicado en 2016

Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.

artículo científico publicado en 2013

Ovarian Cancer Stem Cell Heterogeneity

artículo científico publicado en 2019

Ovarian cancer specific kallikrein profile in effusions

article

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer

artículo científico publicado en 2006

Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

artículo científico publicado en 2013

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium

scientific article published on 10 September 2019

Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis

artículo científico publicado en 2024

Perception of Labial Size and Objective Measurements-Is There a Correlation? A Cross-Sectional Study in a Cohort Not Seeking Labiaplasty

scientific article published on 07 January 2020

Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study

scientific article published on 23 September 2009

Platinum or nonplatinum in recurrent ovarian cancer: that is the question

artículo científico publicado en 2017

Pooled Analysis of the Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients With Ovarian Cancer ⬇️

artículo científico publicado el 1 de junio de 2013

Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria

artículo científico publicado en 2016

Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix

artículo científico publicado en 2008

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients ⬇️

artículo científico publicado el 8 de enero de 2011

Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer

artículo científico publicado en 2002

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement

artículo científico

Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.

artículo científico publicado en 2009

Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis o

scientific article published on 07 March 2008

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

artículo científico publicado en 2013

Recurrence of genitals warts in pre-HPV vaccine era after laser treatment

scientific article published on 08 July 2019

Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer

artículo científico publicado en 2011

Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment

artículo científico publicado en 2010

Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer

artículo científico publicado en 2007

Role of forkhead box protein 3 expression in invasive breast cancer

scientific article published on 01 October 2007

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

artículo científico publicado en 2011

Role of pertuzumab in the treatment of HER2-positive breast cancer

artículo científico publicado en 2012

Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications

artículo científico

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

artículo científico publicado en 2008

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

artículo científico publicado en 2015

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients

artículo científico publicado en 2014

Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer

artículo científico publicado en 2007

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Surgical and systemic management of endometrial cancer: an international survey

artículo científico publicado en 2014

TNFα signalling predicts poor prognosis of patients with endometrial cancer

artículo científico publicado en 2020

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

artículo científico publicado en 2015

The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer

artículo científico publicado en 2012

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

artículo científico publicado en 2005

The miR-34 family and its clinical significance in ovarian cancer

scientific article published on 13 January 2020

The prognostic impact of bone marrow micrometastases in women with breast cancer

artículo científico publicado en 2009

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study

artículo científico publicado en 2015

Trabectedin + pegylated liposomal doxorubicin in third-line treatment of platinum-sensitive relapsed ovarian cancer: a case study

artículo científico publicado en 2018

Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology

artículo científico publicado en 2011

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo

artículo científico publicado en 2004

Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin--an evaluation of the therapeutic index with special emphasis on cardiac toxicity

artículo científico publicado en 2009

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

artículo científico publicado en 2019

Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response

artículo científico publicado en 2017

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer

artículo científico publicado en 2019

Ultrasound-guided core needle biopsy of the breast: does frozen section give an accurate diagnosis?

artículo científico publicado en 2007

Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas

artículo científico publicado en 2010

Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer

artículo científico publicado en 2010

Use of IP chemotherapy in ovarian cancer: the critical questions

artículo científico publicado el 1 de febrero de 2011

Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma

artículo científico publicado en 2008

Why did p53 gene therapy fail in ovarian cancer?

artículo científico publicado en 2003

[Adjuvant therapy of breast cancer with trastuzumab]

artículo científico publicado en 2008

hCDC4 gene mutations in endometrial cancer

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda